What is the recommended follow‑up for a patient with mild transaminitis (alanine aminotransferase 108 U/L)?

Recommended Follow-Up for Mild Transaminitis (ALT 108 U/L)

For a patient with ALT 108 U/L (approximately 2-3 times the upper limit of normal), you should immediately initiate a targeted diagnostic workup rather than simply repeating the test and waiting, as this level of elevation warrants investigation for underlying liver disease that could progress to significant morbidity. 1

Why Not Just Repeat and Wait?

The 2018 British Society of Gastroenterology guidelines explicitly challenge the outdated practice of simply repeating abnormal liver tests 1. The magnitude of ALT elevation does not correlate with prognosis—what matters is the underlying diagnosis. A patient with hepatitis C and normal ALT can progress to end-stage liver disease if not investigated, while someone with ALT >1000 U/L from acute hepatitis A will recover regardless 1. Simply repeating tests delays diagnosis and is not cost-effective unless you've identified a specific acute insult that you expect to resolve 1.

Initial Diagnostic Workup

Proceed with the following serologic and metabolic evaluation immediately 2, 3, 4:

Essential First-Line Tests:

• Viral hepatitis screening: Hepatitis B surface antigen, hepatitis C antibody 2, 3, 4
• Metabolic assessment: Fasting glucose, lipid profile (triglycerides, cholesterol), BMI calculation 3, 4
• Iron studies: Serum iron, total iron-binding capacity, ferritin (for hemochromatosis) 3, 4
• Complete blood count with platelets 3, 4
• Serum albumin and prothrombin time (assess synthetic function) 2, 5

Critical History Elements:

• Alcohol consumption (quantify drinks per week—alcoholic liver disease is a leading cause) 3, 4
• All medications, supplements, herbs, over-the-counter drugs (drug-induced liver injury is common) 2, 3
• Risk factors for metabolic dysfunction-associated steatotic liver disease (MASLD): obesity, diabetes, hypertension, dyslipidemia 3, 4

Special Consideration for Hepatitis C

At ALT 108 U/L, you're in the 70-100 U/L range where hepatitis C prevalence is 10-fold higher than the general population (1.2%) 6. This makes HCV screening particularly important even if other explanations seem plausible 6.

If Initial Testing Points to MASLD

If the workup suggests MASLD (metabolic risk factors present, negative viral/iron studies), calculate a FIB-4 Index Score or NAFLD Fibrosis Score to stratify fibrosis risk 3, 4. This determines whether the patient needs:

• Hepatology referral (high-risk scores)
• Hepatic ultrasonography 4
• Lifestyle modification trial with close monitoring (low-risk scores) 3, 4

When to Pursue Uncommon Causes

If common causes are excluded and ALT remains elevated, test for 3, 7, 4:

• Alpha-1-antitrypsin deficiency (alpha-1-antitrypsin level)
• Autoimmune hepatitis (ANA, smooth muscle antibody, liver/kidney microsomal antibody type 1)
  • Note: Recent 2026 data shows that in ANA-positive patients with ALT <101 U/L without cirrhosis, only 9% have autoimmune hepatitis-compatible histology, and liver biopsy can often be deferred 8
• Wilson disease (ceruloplasmin—especially if age <40)
• Celiac disease (tissue transglutaminase antibody)
• Thyroid disorders (TSH)

Timeline for Escalation

• If ALT remains elevated for 6 months or more despite addressing reversible causes, refer to hepatology for consideration of liver biopsy 2, 7
• If patient has signs of chronic liver disease or hepatic decompensation (ascites, encephalopathy, abnormal albumin/PT), expedite evaluation and referral 2

Universal Counseling

Regardless of etiology, counsel all patients with elevated transaminases on 3:

• Alcohol moderation or cessation
• Weight loss if overweight/obese
• Avoidance of hepatotoxic medications

Common Pitfall to Avoid

Do not assume that mild elevation means benign disease. The most common causes of chronic liver disease leading to cirrhosis—MASLD, alcoholic liver disease, and hepatitis C—frequently present with only mild transaminase elevations 1. Many patients with significant fibrosis have liver enzymes in the normal range 1. The clinical context and systematic investigation matter more than the absolute ALT value.